TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has successfully completed an implementation of its regional patient flow and whole-system visibility platform, SHREWD, to support improved patient flow and safer, more effective care coordination.
SHREWD is a real-time operational management platform which supports – and gathers data from – hospitals, long-term care facilities, community & cancer care services, inter-facility transport services, ambulance and paramedic services, and telehealth services. The platform provides an operational solution for whole-system visibility that is used as a single source of the truth in real-time, leveraging existing Health Information Systems to provide intelligent insights that allow key decision-makers and clinicians to take the right action at the right time.
SHREWD is enabling the Winnipeg Regional Health Authority (“WRHA”) to leverage data from a wide variety of disparate information systems across the health network, aggregated to provide them with visibility of system pressures at a glance. SHREWD is supporting quality improvement and optimized patient flow across the acute facilities and will soon be adding support for three hybrid facilities in the region. The WRHA has been using VitalHub’s Oculys patient flow & operational visibility suite of solutions since 2015. The SHREWD platform is now delivering the next evolution of system integration and regional visibility to improve patient flow.
The WRHA and Shared Health Manitoba now join the likes of organizations like the National Health Service of England (“NHS England”), who has implemented SHREWD across System Coordination Centres to power command centers located across England. SHREWD also provides NHS England with their National Urgent & Emergency Care Coordination Centre, which provides local, regional, and national teams with access to patient flow information from across the country in support of a fully integrated health and care system.
“Regional collaboration plays an important role in our ever-changing healthcare landscape by supporting better care coordination and enhancing the services we provide to both Winnipeg residents and our surrounding communities. The ability to not only view where pressures are across our system, but also to understand why they’re occurring and see the actions required to relieve them, means SHREWD allows us to balance resources intelligently to support the parts of our system under stress,” said Mike Nader, President and Chief Executive Officer, WRHA.
“Collating real time demand & volume and providing an ability to view data across multiple facilities within a single place makes SHREWD a powerful tool to have at our disposal. The increased whole-system visibility into pressures across the Winnipeg region lets us see what’s coming our way so we can plan appropriately and take action, further supporting our ability to take a more proactive approach to regional patient flow,” said Katherine Graham, Executive Director, Acute & Community Care Coordination, WRHA.
“We’ve learned that when a bottleneck exists in one part of a health care system, it doesn’t take long for that bottleneck to negatively impact upstream services and other supports around it,” said Niels Tofting, Executive Vice President & Managing Director, North America at VitalHub. “SHREWD will now provide stakeholders across the Winnipeg region with an early-warning system and a single source of truth they can use to easily identify where pressures in the system are, what they are related to, why they are happening, and the actions requires to relieve them.”
About the Winnipeg Regional Health Authority
The WRHA serves a population of more than 750,000 people, including residents of the city of Winnipeg and the rural municipalities of East and West St. Paul. It also provides healthcare support and speciality referral services to nearly half a million Manitobans who live beyond these boundaries, as well as residents of northwestern Ontario and Nunavut, who often require the services and expertise available within the WRHA.
Among the largest employers in Manitoba, the WRHA and its associated operating entities employs approximately 18,000 people. With an annual operating budget of $2.2 billion, the WRHA is the largest health authority in the province and operates or funds over 200 health service facilities and programs.
About Shared Health Manitoba
Shared Health is Manitoba’s provincial health authority, providing provincial planning, health services and operational support for Manitoba’s health system.
Shared Health is a designated bilingual health authority which has more than 18,000 employees working in all aspects of health care across Manitoba. Our teams work closely with Manitoba’s cancer authority and the five regional health authorities.
About VitalHub
VitalHub is a leading software company dedicated to empowering Health and Human Services providers with solutions designed to simplify the user experience and optimize outcomes. Our clients include hospitals, regional health authorities, mental health and addictions services providers for children and adults, long-term care facilities, home health agencies, correctional services, and community and social services providers.
VitalHub’s comprehensive suite of SaaS solutions include:
The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently VitalHub serves more than 1,000 clients across Canada, USA, UK, Australia, the Middle East, and Europe.
VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The VitalHub team comprises more than 500 team members globally. The Company is publicly traded on the Toronto Stock Exchange (TSX) under the symbol "VHI" and on the OTC Markets OTCQX Exchange under the symbol "VHIBF".
Contact Information
Christian Sgro, CPA, CA, CFA
Head of IR and M&A Specialist
(416) 277-3776
This email address is being protected from spambots. You need JavaScript enabled to view it.
Dan Matlow
Chief Executive Officer, Director
(416) 727-9061
This email address is being protected from spambots. You need JavaScript enabled to view it.
Cautionary Statement
Certain statements contained in this news release may constitute "forward-looking information" or "financial outlook" within the meaning of applicable securities laws that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information or financial outlook. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
Last Trade: | C$11.15 |
Daily Volume: | 45,406 |
Market Cap: | C$586.600M |
December 17, 2024 November 13, 2024 October 30, 2024 August 08, 2024 July 30, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB